Connect with us

Artificial Intelligence

Leading Digital Analytics And Digital Therapeutics Companies Mix Music And Data To Help Survivors Of Stroke

Vlad Poptamas

Published

on

Reading Time: 3 minutes

 

Health Catalyst, Inc. and MedRhythms, Inc. are teaming up to help the millions of Americans who are survivors of stroke to access a promising new digital therapeutic that uses sensors, music and artificial intelligence to measure and improve walking. The agreement is the first for Health Catalyst’s new life sciences business, which aims to align providers, patients, and life science companies through its physician ecosystem and evidence derived from its partnership with many of the nation’s largest health systems encompassing more than 100 million patient records.

Each year, more than 795,000 Americans suffer a stroke, according to the Centers for Disease Control and Prevention. Many are left unable to walk or talk normally and require extensive care and rehabilitation, with total costs estimated at $34 billion a year. While existing therapies for these patients rely mainly on one-on-one physical therapy, MedRhythms has developed a neuroscience-based approach to treatment, employing the principles of rhythmic auditory stimulation (RAS). RAS has been shown in over 50 clinical research studies to improve walking for patients with stroke, traumatic brain injury, multiple sclerosis, cerebral palsy, and Parkinson’s Disease.

The partnership between Health Catalyst and MedRhythms represents a new dynamic for improving outcomes for patients with neurologic injury or disease. The companies will deploy new methods for pinpointing patients who could benefit from MedRhythms’ digitally-forward therapeutics, accurately measuring their clinical outcomes and enabling MedRhythm’s integration within the provider clinical workflow.

“One of the biggest challenges facing life science companies is how to integrate their products within the clinical workflow so they are able to improve patient outcomes,” said Elia Stupka, PhD, general manager of Health Catalyst’s life science business. “Health Catalyst will leverage our services and relationships with some of the nation’s largest provider organizations to develop a convenient means of providing MedRhythms’ products and those of life science companies in general within the clinical workflow, in a manner that’s respectful of clinicians’ existing care processes.”

Under the agreement, Health Catalyst will use real-world data and analytic applications to identify unmet medical needs within the care of neurologic injury and disease. The methodology leverages Health Catalyst’s analytics to uncover variation in outcome metrics and care within healthcare organizations. As best practices for patient care are identified through this process and put into practice by provider organizations, patients are identified as potential beneficiaries of a new medication or digital therapy such as MedRhythms product. By standardizing the way in which both clinical outcomes and cost reductions are measured, a reliable framework can be developed to measure effectiveness and structure outcome-based pricing that can be applied to the digital therapy.

“This partnership with Health Catalyst is a true milestone in our effort to develop digital therapeutics based on the neuroscience of music,” said Owen McCarthy, President and co-founder of MedRhythms. “We’re confident that the combination of Health Catalyst’s data and analytics expertise, and its nationwide customer base of provider organizations, offer an unprecedented opportunity to achieve MedRhythms’ mission and vision of making a high-quality clinical impact in the lives of millions of people.”

“This partnership comes at a crucial time in the digital therapeutics industry,” said Carlos Rodarte, senior vice president of strategy and business development for the life sciences at Health Catalyst, and renowned thought leader in digital health. “Several companies in this field have completed or are completing important trials demonstrating the significant clinical impact of true, validated and regulated digital therapeutics, paving the way for an entire new industry in digital health which has disruptive potential globally to deliver rapid, efficient therapies for patients with unmet needs. We are excited to leverage our technological platform, outcome expertise and trusted network of providers to support digital therapeutics companies like MedRhythms.”

“We believe it’s time for a trusted company with proven expertise to take a different run at building partnerships between providers and life science companies, as a neutral party focused on improved health and wellness for patients,” said Dr. Stupka. “This agreement with MedRhythms aligns perfectly with our mission of serving as a catalyst for massive, sustained improvements in healthcare outcomes.”

 

SOURCE MedRhythms, Inc.

Hello!


Thank you for visiting my profile and thank you for reading my news and published press release!


There a many things that shape a man, but the carving is done by the hobbies and passions. I've pursued two main careers, professional photography and webdesign, while also keeping a passion for automobiles, technology and games. At PICANTE NEWS, I take care of news editing and press release publishing in se
veral categories and as I've mentioned, during my spare time, I am also a professional photographer with webdesign skills.

My future plans include developing more journalistic skills and start creating investigative journalism. You can find my reports and press release coverages in the following categories:


BANKING/FINANCIAL SERVICES, COMPUTER ELECTRONICS, AUTOMOTIVE, CONTRACTS, ANALYSIS, INTERNET TECHNOLOGY, BIOTECHNOLOGY, BLOCKCHAIN, ACQUISITIONS, RETAIL, and many more.



You can get in touch to discuss interviews or possible article submissions by contacting us.


Let's also connect via social media! You can find me on Facebook or visit my photo portfolio.

Advertisement
Comments

Artificial Intelligence

5-Star Destination, Tokyo Station Hotel, Adopts Bebot, Bespoke’s AI-powered Travel Concierge

Vlad Poptamas

Published

on

Reading Time: 1 minute

 

Bespoke, creators of the world’s first AI-powered chatbot developed for travelers, today announce Tokyo Station Hotel, an independent 5-star hotel in Tokyo, has adopted Bebot to serve guests. Through Bespoke’s unique travel-focused AI, Bebot provides hotel guests with an intuitive, responsive and friendly channel to ask any questions that arise during a hotel visit. Guests can make requests for recommendations, reservations and services, or ask specific questions related to their travel experience – all through chat. With Bespoke’s recent launch into the US Market, Bebot is now available for US-based hotels and travel destinations.

Bespoke’s world-leading, unique travel-focused AI is augmented by on-the-ready, seamless, human chat to continuously improve, teach and optimize their AI technology, providing customers and travelers with a no-compromise, reliable source of information. Bebot’s advanced AI was developed to provide travelers with essential information and tips in an intuitive and familiar, yet powerful chat service – providing essential and inspiring tips and information to improve guests’ visits, while relieving hotel staff.

“Tokyo Station Hotel is one of few independent 5-star hotels, and we’re honored they choose Bebot to serve their guests,” said Akemi Tsunagawa, founder and CEO of Bespoke. “Our unique AI was developed from the ground up to serve the specific needs of travelers providing them with the timely info, tips and guidance they need to have a comfortable stay wherever they go.”

In addition to providing information about services, rates, amenities, menu options and directions, Bebot provides travelers with vital details about nearby attractions, destinations and more. Travelers access Bebot by scanning a QR code found on a placard or by visiting a url provided by the hotel – no additional downloads are necessary.

 

SOURCE Bespoke

Continue Reading

Artificial Intelligence

Mercari Opens Cambridge Engineering Offices

Vlad Poptamas

Published

on

Reading Time: 1 minute

Mercari, The Selling App, today announced the opening of engineering offices in Cambridge, MA, advised by two renowned professors at the adjacent Massachusetts Institute of Technology (MIT).

Mercari is the number-one marketplace in Japan. Since entering the U.S. in 2014, more than 45 million Americans have downloaded the app.

At the moment, Mercari’s team in Cambridge is focused on better understanding sellers and buyers, and predicting their intentions ahead of their actions. This helps Mercari deliver a more personalized experience using its recommendation engine. The team is applying machine learning on massive amounts of data to better personalize the user experience based on their preferences, history and interactions.

More broadly, this team is pursuing applied research projects in machine learning, computer vision and other emerging technologies that can help Mercari to make selling even easier than buying.

“Opening the Mercari engineering offices in Cambridge is an important addition to our global technology centers in Palo Alto and Tokyo,” said Dr. Mok Oh, chief technology officer for Mercari U.S. “The expectations of Mercari sellers and buyers are always evolving, so it’s vital that we harness emerging technologies to continuously improve our app and services.”

Advising the team are Dr. Frédo Durand and Dr. Wojciech Matusik of MIT.

Dr. Frédo Durand is a renowned researcher and professor in computer vision and computational photography. He is a professor of Electrical Engineering and Computer Science at MIT, and a member of MIT’s Computer Science and Artificial Intelligence Laboratory (CSAIL).

Dr. Wojciech Matusik is widely-recognized professor and entrepreneur in machine learning, 3D vision, and 3D fabrications. He is a professor of Electrical Engineering and Computer Science at the Computer Science and Artificial Intelligence Laboratory (CSAIL) at MIT, where co-directs the Computer Graphics Group and teaches machine learning courses

Mercari is looking for talented people to join its technology teams in Palo Alto and Cambridge. A list of all current U.S. openings is here.

 

SOURCE Mercari

Continue Reading

Artificial Intelligence

Chinsay’s Intelligent Contract Platform Enables Rio Tinto & Cargill to Complete the First Fully Digitalised Iron Ore Trade

Vlad Poptamas

Published

on

Photo source: salestechstar.com
Reading Time: 1 minute

 

Chinsay, the leading provider of contract digitalisation solutions in the commodity and freight markets, is announcing today the completion of the first fully digitalised iron ore trade, through a trial achieved in partnership with Rio Tinto and Cargill‘s Metals business on Chinsay’s Intelligent Contract Platform (ICP).

In using ICP, Rio Tinto and Cargill collaborated on a single platform to dramatically reduce the time it takes to create, issue and approve commodity contracts from several days to under two hours. The digitalisation of this fundamental trade process creates the opportunity to automate and deliver post-trade efficiencies by linking front-, middle- and back-office functions.

Colin Hayward, Chinsay CEO, said: “This is a technological milestone for the industry, and we are delighted Rio Tinto and Cargill Metals chose to partner with us and use our ICP as the core technology to create this advance. We are constantly collaborating with clients, market participants, tech vendors and industry consortia to extend digitalisation further along the commodity trade lifecycle.”

“The Intelligent Contract Platform is a great tool that has the potential to benefit the entire ferrous industry,” said Lee Kirk, Managing Director for Cargill’s Metals business. “This is a great example of how we can leverage advancements in technology to benefit from increased speed, transparency and efficiencies that enable us to serve our customers and suppliers better.”

ICP is state-of-the-art technology which allows companies to digitalise pre-trade processes early in the deal lifecycle, creating an agreed contract dataset that can be seamlessly integrated with other operational systems, functions and processes, enabling transparency and traceability across the supply chain.  ICP prepares clients for the use of technologies such as blockchain, ML, AI and electronic trade documentation solutions.

 

SOURCE Chinsay

Continue Reading

Font Resizer

Subscribe to PICANTE via Email

Enter your email address to subscribe to PICANTE and receive notifications of new posts by email.

Follow us on Facebook

Read more from our authors

Follow our Tweets

Trending

Please turn AdBlock off